BioSpace News Archive

Bayer announced the U.S. Food and Drug Administration has accepted the New Drug Application and granted Priority Review to darolutamide for the treatment of non-metastatic castration-resistant prostate cancer.

A Total of 26 Podium Presentations and Posters to be Featured

St. Jude PLAY LIVE celebrates $12 million raised, kicks off another fundraising season

More than $500,000 in Grants to be Awarded to Help Close the Health Disparity Gap in North Philadelphia

World-Renowned Entertainment Destination’s Long-Standing Partnership Helps to Grant More Than 1,000 Life-Changing Wishes [29-April-2019] DALLAS , APRIL 29, 2019 /PRNewswire/ -- In honor of World Wish Day ® , which celebrates the hundreds of thousands of life-changing wishes Make-A-Wish ® has granted, Dave & Buster’s is announcing its commitment to make 20

Second abstract with data concluding vibegron does not inhibit CYP2D6, a common drug metabolism pathway, also accepted for podium presentation

Iktos, a company specializing in Artificial Intelligence technologies applied to new drug design, announced the initiation of a collaboration agreement with Janssen Pharmaceutica NV.

TraceLink Inc., the world’s largest integrated digital supply network providing real-time information sharing for better patient outcomes, announced the speaker lineup and newly introduced Advisory Board for FutureLink Barcelona.

Developing novel methods to expand gene-modified stem cells to achieve higher cell doses

Additional independent directors to help advance Kraig Labs’ business model